News Focus
News Focus
Followers 26
Posts 1424
Boards Moderated 0
Alias Born 02/07/2010

Re: patientlywaiting post# 320792

Friday, 12/15/2017 7:58:24 AM

Friday, December 15, 2017 7:58:24 AM

Post# of 347009
And let us not forget PW, that Ronin was able to see all the value in AVID without AVID detailed financial reporting. Also, it doesn't appear like last Q's financials were very good based upon the PPS response to the CC.

I'm also confused as to those that think King is gone.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(c) On December 10, 2017, Peregrine Pharmaceuticals, Inc. (the “Company”) appointed Roger J. Lias, Ph.D., who currently serves as the President of Avid Bioservices, Inc., the Company’s wholly-owned subsidiary, as the Company’s principal executive officer. The discussion contained in Item 5.02 of the Current Report on Form 8-K filed by the Company on September 14, 2017 relating to Dr. Lias is incorporated into this Item 5.02 by reference. No new or additional compensatory arrangements were entered into in connection with Dr. Lias’ appointment as principal executive officer.



Lias is not named CEO, and if King is gone, either this 8K or a separate filing would have to acknowledge that King has left or at least replaced as CEO.

FFTT

JBAIN
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y